AI assistant
Blend Labs, Inc. — Director's Dealing 2021
Jul 16, 2021
32251_dirs_2021-07-15_ee851161-1762-4640-9f74-a2f3257b1b8e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Blend Labs, Inc. (BLND)
CIK: 0001855747
Period of Report: 2021-07-15
Reporting Person: Sumner Crystal (Head of Legal, Compliance,Risk)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Class A Common Stock | 396346 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $0.54 | 2026-08-21 | Class A Common Stock (27289) | Direct | |
| Stock Option (right to buy) | $0.87 | 2028-12-16 | Class A Common Stock (160000) | Direct | |
| Stock Option (right to buy) | $2.31 | 2030-03-28 | Class A Common Stock (333333) | Direct | |
| Stock Option (right to buy) | $8.58 | 2031-03-30 | Class A Common Stock (200000) | Direct | |
| Stock Option (right to buy) | $8.58 | 2031-03-30 | Class A Common Stock (15000) | Direct |
Footnotes
F1: Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Class A Common Stock as currently named will be reclassified into one share of Class B Common Stock and each share of Class B Common Stock as currently named will be reclassified into one share of Class A Common Stock. This Form 3 assumes all shares have been renamed as if such reclassification has already occurred.
F2: The shares subject to this option are fully vested and immediately exercisable.
F3: 1/48th of the shares subject to this option vest monthly following January 1, 2020, subject to the Reporting Person's continued role as a service provider to the Issuer. This option is subject to an early exercise provision and is immediately exercisable.
F4: 1/24th of the shares subject to this option vest monthly following February 1, 2024, subject to the Reporting Person's continued role as a service provider to the Issuer. This option is subject to an early exercise provision and is immediately exercisable.
F5: The shares subject to this option will be fully vested and exercisable on January 1. 2023. This option is subject to an early exercise provision and is immediately exercisable.